vspВопросы современной педиатрииCurrent Pediatrics1682-55271682-5535Издательство «ПедиатрЪ»vsp-1262Research ArticleОБМЕН ОПЫТОМEXCHANGE OF EXPERIENCEВОССТАНОВЛЕНИЕ МИКРОБИОЦЕНОЗА КИШЕЧНИКА В КОМПЛЕКСНОЙ ТЕРАПИИ АТОПИЧЕСКОГО ДЕРМАТИТА У ДЕТЕЙRESTORATION OF MICROBIOCENOSIS OF THE INTESTINES WITHIN THE COMPLEX THERAPY FOR ATOPIC DERMATITIS IN CHILDRENМельниковаИ.Ю.Mel'nikovaI.Yu.ГорюноваМ.М.GoryunovaM.M.СамсоноваМ.В.SamsonovaM.V.Санкт-Петербургская медицинская академия последипломного образованияРоссияSaint Petersburg Medical Academy of the Postgraduate EducationRussian Federation20072110201564Вопросы современной педиатрии123127Copyright © Мельникова И., Горюнова М., Самсонова М., 20072007Мельникова И., Горюнова М., Самсонова М.Mel'nikova I., Goryunova M., Samsonova M.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://vsp.spr-journal.ru/jour/article/view/1262ReferencesIsolauri E., Grоnlund M.M., Salminen S. et al. Why don't we bud? J. Pediatr. Gastroenterol. Nutr. 2000; 30 (4): 214–216.Isolauri E., Grоnlund M.M., Salminen S. et al. Why don't we bud? J. Pediatr. Gastroenterol. Nutr. 2000; 30 (4): 214–216.Sudo N., Sawamura S., Tanaka K. The requirement of intestinal bacteria flora for the development of an IgE production system fully susceptible to oral tolerance induction. J. Immunology. 1997; 159 (6): 1739–1745.Sudo N., Sawamura S., Tanaka K. The requirement of intestinal bacteria flora for the development of an IgE production system fully susceptible to oral tolerance induction. J. Immunology. 1997; 159 (6): 1739–1745.Isolauri E. Probiotics in the prevention and treatment of allergic disease. Pediatric Allergology and Immunology. 2001; 12 (4): 56–59.Isolauri E. Probiotics in the prevention and treatment of allergic disease. Pediatric Allergology and Immunology. 2001; 12 (4): 56–59.Kalliomaki M., Salminen A., Arvilommi H. et al. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet. 2001; 357 (9262): 1076–1079.Kalliomaki M., Salminen A., Arvilommi H. et al. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet. 2001; 357 (9262): 1076–1079.Isolauri E., Rautava S., Kalliomaki M. еt al. Role of probiotics in food hypersensitivity. Current Opinion in Allergy and Clinical Immunology. 2002; 2: 236–271.Isolauri E., Rautava S., Kalliomaki M. еt al. Role of probiotics in food hypersensitivity. Current Opinion in Allergy and Clinical Immunology. 2002; 2: 236–271.Matricardi P.M., Bjorksten B., Bonini S. et al. For the EAACI Task Force 7. Microbial products in allergy prevention and therapy. Allergy. 2003; 58: 461–471.Matricardi P.M., Bjorksten B., Bonini S. et al. For the EAACI Task Force 7. Microbial products in allergy prevention and therapy. Allergy. 2003; 58: 461–471.Rautava S., Kalliomaki M., Isolauri E. Probiotics during pregnancy and breastfeeding might confer immunomodulatory protection against atopic diseases in the infant. J. Allergy. 2002; 109: 119–121.Rautava S., Kalliomaki M., Isolauri E. Probiotics during pregnancy and breastfeeding might confer immunomodulatory protection against atopic diseases in the infant. J. Allergy. 2002; 109: 119–121.Isolauri E., Rautava S., Kalliomaki M. et al. Role of probiotics in food hypersensitivity. Curr. Opin. Allergy Clin. Immunol. 2002; 2 (3): 263–271.Isolauri E., Rautava S., Kalliomaki M. et al. Role of probiotics in food hypersensitivity. Curr. Opin. Allergy Clin. Immunol. 2002; 2 (3): 263–271.Kelly D., Conway S., Aminov R. Commensal gut bacteria: mechanisms of immune modulation. J. Immunology. 2005; 26 (6): 326–323.Kelly D., Conway S., Aminov R. Commensal gut bacteria: mechanisms of immune modulation. J. Immunology. 2005; 26 (6): 326–323.. Шендеров Б.А. Медицинская микробная экология и функциональное питание. Пробиотики и функциональное питание. М.: Грантъ. 2001. Т. 3. С. 288.. Шендеров Б.А. Медицинская микробная экология и функциональное питание. Пробиотики и функциональное питание. М.: Грантъ. 2001. Т. 3. С. 288.Veckman V., Miettinen M., Pirhonen J. et al. Streptococcus pyogenes and Lactobacillus rhamnosus differentially induce maturation and production of Th1 type cytokines and chemokines in human monocyte-derived dendritic cells. J. Leukoc. Biol. 2004; 75 (5): 764–771.Veckman V., Miettinen M., Pirhonen J. et al. Streptococcus pyogenes and Lactobacillus rhamnosus differentially induce maturation and production of Th1 type cytokines and chemokines in human monocyte-derived dendritic cells. J. Leukoc. Biol. 2004; 75 (5): 764–771.
The authors declare that there are no conflicts of interest present.